CXI Healthcare Technology Group Limited

900120KOSDAQFinance

CXI Healthcare Technology Group Limited (900120, KOSDAQ) reported KRW 0bn revenue in 2025.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
202110022Consolidated
202210022Consolidated
202300022Consolidated
202400033Consolidated
202500033Consolidated

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
20214.3%4.9%96.7%1.4%
20226.2%5.9%97.9%1.5%
202310%10.5%99.2%1.7%
202427.2%42.3%99.4%6.3%
202516.9%22.1%99.5%2.5%

Revenue moved -51.3% between 2021 and 2025.

Net profit was positive in the 5 most recent consecutive years on file — every year we hold. Counted from the 5 years in which the company filed a net-profit line — a year with no filing is skipped, not read as a loss.

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 17bn
Close priceKRW 1,040
Listed shares16,669,660
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

When it was founded

The incorporation date on the company's registration record, as filed with Korea's Financial Supervisory Service. This is when the company was legally formed — not when it first listed, and not when the business it grew out of began trading.

Incorporated

Who runs it

Registered representative directors — in Korea this is the office a CEO holds. Filed with the Financial Supervisory Service (DART). A Korean company can register more than one, and the title beside each name is the rank they carry inside the company.

NameTitleBoard seatYears in post
LIN JINSHENGRepresentative Director (CEO)Inside director2 years

Some Roman spellings here are not ours — the company filed them itself, either beside the Korean name or in place of one. Those are the spellings the company uses.

Workforce — a side measure, not the main one

Employees (2025)26
Women8 (30.8%)
Annual pay, menKRW 203,667
Annual pay, womenKRW 126,500
Pay ratio, women to men62.1%

Other companies in Finance

97 listed companies file under this classification. Showing 12.

See the whole Finance list →